Predict your next investment

Corporation
HEALTHCARE | Biotechnology
exagen.com

See what CB Insights has to offer

Founded Year

2002

Stage

IPO | IPO

Total Raised

$156.13M

Date of IPO

9/19/2019

Market Cap

0.17B

Stock Price

9.85

About Exagen

Exagen is a Patient Focused, Discovery Driven, CLIA-certified, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of Rheumatology and Autoimmune diseases. Committed to Personalized Medicine, the company's Avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management.

Exagen Headquarter Location

1261 Liberty Way Suite C

Vista, California, 92081,

United States

+1 760 560 1501

Latest Exagen News

Exagen and Queen Mary University of London Announce Exclusive License and Collaboration Agreement

Jan 10, 2022

Collaboration to develop novel patented molecular signatures for rheumatoid arthritis biologic therapeutic selection SAN DIEGO, Jan. 09, 2022 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, and Queen Mary University of London, announced today the execution of a research collaboration and exclusive license agreement. The collaboration will focus on development and optimization of patent-pending precision … Continue reading "Exagen and Queen Mary University of London Announce Exclusive License and Collaboration Agreement" The post Exagen and Queen Mary University of London Announce Exclusive License and Collaboration Agreement appeared first on Tullis Funds.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Exagen

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Exagen is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

7,888 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

B

Biopharma Tech

818 items

Exagen Patents

Exagen has filed 17 patents.

The 3 most popular patent topics include:

  • Autoimmune diseases
  • Coagulopathies
  • Glucocorticoids
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/10/2012

11/20/2018

Autoimmune diseases, Immune system, Immunology, Inflammations, Rheumatology

Grant

Application Date

2/10/2012

Grant Date

11/20/2018

Title

Related Topics

Autoimmune diseases, Immune system, Immunology, Inflammations, Rheumatology

Status

Grant

Exagen Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Exagen Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.